# US 2023/0301908 A1 · Contact lens product having antioxidative function

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0301908 A1
- Document ID: US20230301908A1
- Status: Published application
- Kind: A1
- Application number: 18/132,144
- Filed: 2023-04-07
- Published: 2023-09-28
- Earliest claimed: 2019-06-27
- Assignees: Pegavision Corporation
- Applicants: Pegavision Corporation
- Inventors: CHUN-HAN CHEN; WAN-YING GAO
- Web page: https://patentgrep.com/patent/US20230301908A1

## CPC

- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61L 12/14: Organic compounds not covered by groups A61L12/10 or A61L12/12
- A45C 11/005: {Contact lens cases (A45C11/046 takes precedence)}
- A61K 9/5115: {Inorganic compounds}
- A61K 33/242: Gold; Compounds thereof
- A61K 47/12: Carboxylic acids; Salts or anhydrides thereof
- A61K 47/20: containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A61K 47/545: {Heterocyclic compounds (A61K47/558 takes precedence)}
- A61K 47/61: the organic macromolecular compound being a polysaccharide or a derivative thereof
- A61P 27/00: Drugs for disorders of the senses
- A61P 27/02: Ophthalmic agents
- A61K 9/0048: {Eye, e.g. artificial tears}
- G02C 7/04: Contact lenses for the eyes (disinfection or sterilisation of contact lenses A61L12/00)
- G02C 13/008: {Devices specially adapted for cleaning contact lenses}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A45C: PURSES; LUGGAGE; HAND CARRIED BAGS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- G02C: SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES (trial frames for testing the eyes A61B3/04; goggles or eyeshields not having the same features as spectacles A61F9/00)

## Abstract

A contact lens product having an antioxidative function includes a composition in the form of a solution. The composition includes gold nanoparticles and at least one non-enzymatic antioxidant. The gold nanoparticles are present in an effective concentration from 0.01 ppm to 3000 ppm and have an average particle size from 0.5 nm to 40 nm. The at least one non-enzymatic antioxidant is present in an amount greater than 0 wt% and less than 20 wt% based on the composition being 100 wt%.

## Claims

### Claim 1

A contact lens product having an antioxidative function, comprising a composition in the form of a solution that includes gold nanoparticles and at least one non-enzymatic antioxidant, wherein the gold nanoparticles are present in an effective concentration from 0.01 ppm to 3000 ppm and have an average particle size from 0.5 nm to 40 nm, and the at least one non-enzymatic antioxidant is present in an amount greater than 0 wt% and less than 20 wt% based on the composition being 100 wt%.

### Claim 2 (depends on 1)

The contact lens product according to claim 1, further comprising a contact lens that is immersed in the composition.

### Claim 3 (depends on 1)

The contact lens product according to claim 1, wherein the effective concentration of the gold nanoparticles is from 1 ppm to 400 ppm.

### Claim 4 (depends on 1)

The contact lens product according to claim 1, wherein the amount of the at least one non-enzymatic antioxidant is from 0.05 wt% to 3 wt%.

### Claim 5 (depends on 1)

The contact lens product according to claim 1, wherein the gold nanoparticles are surface-modified with a hydrophilic functional group that includes at least one of OH moiety, CONH moiety, CONH2 moiety, and COOH moiety.

### Claim 6 (depends on 1)

The contact lens product according to claim 1, wherein the gold nanoparticles are surface-modified with a phenol group-containing compound that is selected from monophenol, polyphenol, and flavonoid compounds.

### Claim 7 (depends on 1)

The contact lens product according to claim 1, wherein the gold nanoparticles are surface-modified with a polysaccharide substance that is selected from uronic acids, methyl carboxylic acid chitin, methyl carboxylic acid chitosan, alginic acid, and hyaluronic acid.

### Claim 8 (depends on 1)

The contact lens product according to claim 1, wherein the gold nanoparticles are surface-modified with a peptide substance having a molecular weight from 300 Daltons to 300,000 Daltons.

### Claim 9 (depends on 1)

The contact lens product according to claim 1, wherein the gold nanoparticles have lipoic acid or dihydrolipoic acid bonded thereon.

### Claim 10 (depends on 1)

The contact lens product according to claim 1, wherein the composition has a pH from 6 to 8 and an osmotic pressure from 240 osmol/kg to 400 osmol/kg.
